drug
atorvastatin calcium
Marketedupdated 3mo agoby CMP Pharma Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval32 co-mentions · 16 sources
- drugatorvastatin21 co-mentions · 21 sources
- drugLipitor21 co-mentions · 21 sources
- tagSmall Molecule16 co-mentions · 16 sources
- companyAscend Laboratories Ltd8 co-mentions · 4 sources
- tagRecall5 co-mentions · 5 sources
- companyAlkem Laboratories Ltd4 co-mentions · 4 sources
- companyBiocon Pharma Ltd2 co-mentions · 1 sources
indications
investigational
Hyperlipidemia
all catalysts(0)
nothing on the calendar yet
Trials studying atorvastatin calcium
- phase1A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy Participants
- phase2Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period.
- phase1Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin
- phase1A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin
- phase4Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes
- phase3Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)
- phase4Statin Therapy for Ischemic and Nonischemic Cardiomyopathy
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jun 7, 2037
~10.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (5)
- Jun 7, 2037formulationUS 11369567
- Jun 7, 2037formulationUS 11654106
- Jun 7, 2037formulationUS 11925704
- Jun 7, 2037formulationUS 12168069
- Jun 7, 2037formulationUS 12370136
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 16m ago
Found something off?
comments(0)
5-min edit window · permanent after that